GB9302622D0 - Heteroaromatic compounds - Google Patents

Heteroaromatic compounds

Info

Publication number
GB9302622D0
GB9302622D0 GB939302622A GB9302622A GB9302622D0 GB 9302622 D0 GB9302622 D0 GB 9302622D0 GB 939302622 A GB939302622 A GB 939302622A GB 9302622 A GB9302622 A GB 9302622A GB 9302622 D0 GB9302622 D0 GB 9302622D0
Authority
GB
United Kingdom
Prior art keywords
heteroaromatic compounds
heteroaromatic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939302622A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB939302622A priority Critical patent/GB9302622D0/en
Publication of GB9302622D0 publication Critical patent/GB9302622D0/en
Priority to ZA94891A priority patent/ZA94891B/xx
Priority to IL10860194A priority patent/IL108601A0/xx
Priority to AU60051/94A priority patent/AU6005194A/en
Priority to EP94906290A priority patent/EP0683778A1/fr
Priority to PCT/GB1994/000265 priority patent/WO1994018196A1/fr
Priority to JP6517819A priority patent/JPH08506337A/ja
Priority to SK991-95A priority patent/SK99195A3/sk
Priority to CA002155758A priority patent/CA2155758A1/fr
Priority to HU9501881A priority patent/HUT73654A/hu
Priority to MX9401080A priority patent/MX9401080A/es
Priority to CN94191142A priority patent/CN1117731A/zh
Priority to CZ952044A priority patent/CZ204495A3/cs
Priority to BG99839A priority patent/BG99839A/bg
Priority to FI953777A priority patent/FI953777A/fi
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB939302622A 1993-02-10 1993-02-10 Heteroaromatic compounds Pending GB9302622D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GB939302622A GB9302622D0 (en) 1993-02-10 1993-02-10 Heteroaromatic compounds
ZA94891A ZA94891B (en) 1993-02-10 1994-02-09 Heteroaromatic compounds
IL10860194A IL108601A0 (en) 1993-02-10 1994-02-09 Piperazine and piperidine derivatives, their preparation and pharmaceutical compositions containing them
CZ952044A CZ204495A3 (en) 1993-02-10 1994-02-10 Heteroaromatic compounds exhibiting antipsychotic activity
JP6517819A JPH08506337A (ja) 1993-02-10 1994-02-10 抗精神活性を有するヘテロ芳香族化合物
EP94906290A EP0683778A1 (fr) 1993-02-10 1994-02-10 Composes heteroaromatiques a activite antipsychotique
PCT/GB1994/000265 WO1994018196A1 (fr) 1993-02-10 1994-02-10 Composes heteroaromatiques a activite antipsychotique
AU60051/94A AU6005194A (en) 1993-02-10 1994-02-10 Heteroaromatic compounds with antipsychotic activity
SK991-95A SK99195A3 (en) 1993-02-10 1994-02-10 Heteroaromatic compounds with antipsychotic effect
CA002155758A CA2155758A1 (fr) 1993-02-10 1994-02-10 Composes heteroaromatiques possedant une activite neuroleptique
HU9501881A HUT73654A (en) 1993-02-10 1994-02-10 Piperazine and piperidine derivatives with antipsychotic activity, pharmaceutical compositions containing them and process for their preparation
MX9401080A MX9401080A (es) 1993-02-10 1994-02-10 Compuestos heteroaromaticos.
CN94191142A CN1117731A (zh) 1993-02-10 1994-02-10 具有抑制精神病活性的芳香杂环化合物
BG99839A BG99839A (bg) 1993-02-10 1995-08-02 Хетероароматни съединения с антипсихотичен ефект
FI953777A FI953777A (fi) 1993-02-10 1995-08-09 Heteroaromaattisia yhdisteitä, joilla on antipsykoottinen aktiivisuus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939302622A GB9302622D0 (en) 1993-02-10 1993-02-10 Heteroaromatic compounds

Publications (1)

Publication Number Publication Date
GB9302622D0 true GB9302622D0 (en) 1993-03-24

Family

ID=10730183

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939302622A Pending GB9302622D0 (en) 1993-02-10 1993-02-10 Heteroaromatic compounds

Country Status (15)

Country Link
EP (1) EP0683778A1 (fr)
JP (1) JPH08506337A (fr)
CN (1) CN1117731A (fr)
AU (1) AU6005194A (fr)
BG (1) BG99839A (fr)
CA (1) CA2155758A1 (fr)
CZ (1) CZ204495A3 (fr)
FI (1) FI953777A (fr)
GB (1) GB9302622D0 (fr)
HU (1) HUT73654A (fr)
IL (1) IL108601A0 (fr)
MX (1) MX9401080A (fr)
SK (1) SK99195A3 (fr)
WO (1) WO1994018196A1 (fr)
ZA (1) ZA94891B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
ES2170177T3 (es) * 1995-03-17 2002-08-01 Aventis Pharma Inc Benzotienilpiperazinas sustituidas, su uso como medicamentos y procedimientos para su preparacion.
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
WO2002039988A2 (fr) * 2000-11-14 2002-05-23 Merck Patent Gmbh Nouvelles utilisations de l'antagoniste combines selectif du recepteur d2 de la dopamine et de l'agoniste du recepteur de la 5-ht¿1a?
EP1361875A2 (fr) * 2001-02-16 2003-11-19 Aventis Pharmaceuticals Inc. Nouveaux derives heterocycliques d'amides et leur utilisation comme ligands du recepteur de la dopamine d3
HUP0402092A3 (en) 2001-07-26 2010-06-28 Merck Patent Gmbh Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts for preparation of pharmaceutical compositions
GB0222909D0 (en) * 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
BRPI0511993A (pt) * 2004-07-20 2008-01-22 Siena Biotech Spa compostos moduladores de receptores de acetilcolina nicotìnicos alfa7, composições farmacêuticas e usos terapêuticos dos mesmos
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
US8981095B2 (en) 2011-07-28 2015-03-17 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of lurasidone and salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
AU593194B2 (en) * 1986-09-26 1990-02-01 Sumitomo Pharmaceuticals Company, Limited Imide derivatives ,and their production and use
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
MX9201991A (es) * 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.

Also Published As

Publication number Publication date
CA2155758A1 (fr) 1994-08-18
JPH08506337A (ja) 1996-07-09
MX9401080A (es) 1994-08-31
SK99195A3 (en) 1995-12-06
IL108601A0 (en) 1994-05-30
CZ204495A3 (en) 1996-03-13
FI953777A0 (fi) 1995-08-09
AU6005194A (en) 1994-08-29
HU9501881D0 (en) 1995-08-28
WO1994018196A1 (fr) 1994-08-18
BG99839A (bg) 1996-02-28
CN1117731A (zh) 1996-02-28
ZA94891B (en) 1995-08-10
EP0683778A1 (fr) 1995-11-29
FI953777A (fi) 1995-08-09
HUT73654A (en) 1996-09-30

Similar Documents

Publication Publication Date Title
GB9405803D0 (en) Heteroaromatic compounds
GB9310978D0 (en) Compounds
GB9302622D0 (en) Heteroaromatic compounds
GB9302016D0 (en) Compounds
GB9315801D0 (en) Compounds
GB9313144D0 (en) Compounds
GB9307400D0 (en) Compounds
GB9315800D0 (en) Compounds
GB9317314D0 (en) Compounds
EP0733044A4 (fr) Composes
GB9310594D0 (en) Compounds
GB9315154D0 (en) Hypolipademic compounds
GB9300088D0 (en) Compounds
GB9320617D0 (en) Compounds
GB9320214D0 (en) Compounds
GB9320186D0 (en) Compounds
GB9318380D0 (en) Compounds
GB9318198D0 (en) Compounds
GB9316954D0 (en) Compounds
GB9300090D0 (en) Compounds
GB9316532D0 (en) Compounds
GB9302027D0 (en) Compounds
GB9314966D0 (en) Compounds
GB9313185D0 (en) Compounds
GB9302619D0 (en) Organiz compounds